- Home
- HUHU vs BOLD Comparison
HUHU vs BOLD Comparison
Compare HUHU & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUHU
- BOLD
- Stock Information
- Founded
- HUHU 2015
- BOLD 2018
- Country
- HUHU China
- BOLD United States
- Employees
- HUHU N/A
- BOLD N/A
- Industry
- HUHU
- BOLD
- Sector
- HUHU
- BOLD
- Exchange
- HUHU NYSE
- BOLD Nasdaq
- Market Cap
- HUHU N/A
- BOLD 54.9M
- IPO Year
- HUHU 2024
- BOLD 2024
- Fundamental
- Price
- HUHU $4.70
- BOLD $2.73
- Analyst Decision
- HUHU
- BOLD Buy
- Analyst Count
- HUHU 0
- BOLD 3
- Target Price
- HUHU N/A
- BOLD $22.50
- AVG Volume (30 Days)
- HUHU 152.2K
- BOLD 132.6K
- Earning Date
- HUHU 02-22-2025
- BOLD 11-07-2024
- Dividend Yield
- HUHU N/A
- BOLD N/A
- EPS Growth
- HUHU 13.14
- BOLD N/A
- EPS
- HUHU 0.08
- BOLD N/A
- Revenue
- HUHU $17,492,735.00
- BOLD N/A
- Revenue This Year
- HUHU N/A
- BOLD N/A
- Revenue Next Year
- HUHU N/A
- BOLD N/A
- P/E Ratio
- HUHU $57.60
- BOLD N/A
- Revenue Growth
- HUHU 33.03
- BOLD N/A
- 52 Week Low
- HUHU $3.52
- BOLD $2.33
- 52 Week High
- HUHU $9.89
- BOLD $15.24
- Technical
- Relative Strength Index (RSI)
- HUHU N/A
- BOLD N/A
- Support Level
- HUHU N/A
- BOLD N/A
- Resistance Level
- HUHU N/A
- BOLD N/A
- Average True Range (ATR)
- HUHU 0.00
- BOLD 0.00
- MACD
- HUHU 0.00
- BOLD 0.00
- Stochastic Oscillator
- HUHU 0.00
- BOLD 0.00
About BOLD Boundless Bio Inc. Common Stock
Boundless Bio Inc is a clinical-stage oncology company. It is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in more than 14% of cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.